SME Times is powered by   
Search News
Just in:   • Global IT spending to grow 3.2% in 2019: Gartner  • Reliance Jio posts Rs 681 crore profit in Q2  • India needs strong, decisive leadership at Centre: Jaitley  • Demanding VAT cut, Delhi petrol pumps to shut on October 22-23  • Must push exports to grow at 9-10 pc annually: NITI chief 
Last updated: 26 May, 2018  

Sun.Pharma.9.Thmb.jpg Sun Pharma's Q4 consolidated net profit up 7%

Sun.Pharma.9.jpg
   Top Stories
» India needs strong, decisive leadership at Centre: Jaitley
» Must push exports to grow at 9-10 pc annually: NITI chief
» Govt preparing roadmap for aviation sector: Prabhu
» Stressed power assets to be viable soon: R K Singh
» Investment cycle rising since 2016, to last till 2022: RBI
SME Times News Bureau | 26 May, 2018
Pharma major Sun Pharmaceutical Industries on Friday reported a rise of 6.96 per cent in its consolidated net profit for the quarter ended March 31, 2018.

According to the company, its profit after tax for the quarter under review increased to Rs 1,308.96 crore from Rs 1,223.71 crore reported for the corresponding quarter of previous fiscal.

However, in terms of financial year, the pharma major's consolidated net profit declined by 68.96 per cent to Rs 2,161.55 crore from Rs 6,964.37 crore reported for 2016-17.

Commenting on the financial performance, Dilip Shanghvi, Managing Director of the Company said: "Our Q4 performance is in-line with our guidance. Over the last four quarters, we have been able to record a gradual improvement in performance despite a challenging US generic pricing environment."

"FY19 will mark the crossing of some important milestones in our specialty journey with the likely launch of 3 specialty products in the US - Ilumya, OTX-101 and Yonsa - which will entail upfront investments. We are also planning to conduct additional clinical trials for a new indication of Ilumya. We will continue to evaluate opportunities in the specialty segment to further enhance this business."
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 19 Oct, 2018
  Daily Poll
Is counterfeiting a major threat to SMEs?
 Yes
 No
 Can't say
  Commented Stories
» Starting an import export business: Basic guide for beginners(8)
» Letter of Credit - a safe and secure payment mode?(1)
» India needs strong, decisive leadership at Centre: Jaitley(1)
» Punjab to give unique number to plots of land to prevent frauds(1)
» All is not well with GDP growth(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter